Variation of M3 muscarinic receptor expression in different prostate tissues and its significance

Saudi Medical Journal

Volumn 30, Issue 8, 2009, Pages 1010-1016

  Song, Wei ^a   Yuan, Mingzhen ^b   Zhao, Shengtian ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALE; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE TUMOR; PROTEIN ANALYSIS; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; METABOLISM; MIDDLE AGED;

AGED; BLOTTING, WESTERN; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349512168     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Rayford W, Noble MJ, Austenfeld MA, Weigel J, Mebust WK, Shah GV. Muscarinic cholinergic receptors promote growth of human prostate cancer cells. Prostate 1997; 30: 160-166.
2. Sydorenko V, Shuba Y, Thebault S, Roudbaraki M, Lepage G, Prevarskaya N, et al. Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells. J Physiol 2003; 548 (Pt 3): 823-836.
3. Blanco M, Robinson MJ. Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue. Ann Diagn Pathol 2004; 8: 333-336.
4. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-479.
5. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 8-31.
6. Pienta KJ. Etiology, epidemiology, and prevention of carcinoma of the prostate. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, editors. Campbell's Urology Vol II. 7th ed. Philadelphia (PA): Saunders; 1998. p. 2489-2496.
7. Yuan M, Zhao S, Wang H. Distribution of cholinergic muscarinic receptor subtypes in different zones of adult human prostate. Chinese Journal of Urology 2007; 28: 482-485.
8. Cheng K, Samimi R, Xie G, Shant J, Drachenberg C, Wade M, et al. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. Am J Physiol Gastrointest Liver Physiol 2008; 295: G591-G597.
9. Bowers JW, Schlauder SM, Calder KB, Morgan MB. Acetylcholine receptor expression in Merkel cell carcinoma. Am J Dermatopathol 2008; 30: 340-343.
10. Song P, Sekhon HS, Lu A, Arredondo J, Sauer D, Gravett C, et al. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res 2007; 67: 3936-3944.
11. de la Torre E, Genaro AM, Ribeiro ML, Pagotto R, Pignataro OP, Sales ME. Proliferative actions of muscarinic receptors expressed in macrophages derived from normal and tumor bearing mice. Biochim Biophys Acta 2008; 1782: 82-89.
12. Rössler OG, Henss I, Thiel G. Transcriptional response to muscarinic acetylcholine receptor stimulation: Regulation of Egr-1 biosynthesis by ERK, Elk-1, MKP-1, and calcineurin in carbachol-stimulated human neuroblastoma cells. Arch Biochem Biophys 2008; 470: 93-102.
13. Kim DR, Rah SH, Sohn JH, Yeh BI, Ko CM, Park JS, et al. Calcium mobilization by activation of M(3)/M(5) muscarinic receptors in the human retinoblastoma. J Pharmacol Sci 2007; 105: 184-192.
14. Blanco M, Robinson MJ. Muscarinic M3 acetylcholine receptor immunostaining in paraffin-embedded normal and neoplastic prostatic gland tissue. Ann Diagn Pathol 2004; 8: 333-336.
15. Kawashima K, Watanabe N, Oohata H, Fujimoto K, Suzuki T, Ishizaki Y, et al. Synthesis and release of acetylcholine by cultured bovine arterial endothelial cells. Neurosci Lett 1990; 119: 156-158.
16. Kawashima K, Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 2000; 86: 29-48.
17. Wessler I, Kirkpatrick CJ, Racké K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther 1998; 77: 59-79.
18. Klapproth H, Reinheimer T, Metzen J, Münch M, Bittinger F, Kirkpatrick CJ, et al. Non-neuronal acetylcholine, a signaling molecule synthesized by surface cells of rat and man. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 515-523.
19. Zia S, Ndoye A, Nguyen VT, Grando SA. Nicotine enhances expression of the alpha 3, alpha 4, alpha 5, and alpha 7 nicotinic receptors modulating calcium metabolism and regulating adhesion and motility of respiratory epithelial cells. Res Commun Mol Pathol Pharmacol 1997; 97: 243-262.
20. Grando SA, Kist DA, Qi M, Dahl MV. Human keratinocytes synthesize, secrete, and degrade acetylcholine. J Invest Dermatol 1993; 101: 32-36.
21. Song P, Sekhon HS, Jia Y, Keller JA, Blusztajn JK, Mark GP, Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res 2003; 63: 214-221.
22. Song P, Sekhon HS, Lu A, Arredondo J, Sauer D, Gravett C, et al. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res 2007; 67: 3936-344.
23. Song P, Sekhon HS, Proskocil B, Blusztajn JK, Mark GP, Spindel ER. Synthesis of acetylcholine by lung cancer. Life Sci 2003; 72: 2159-2168.
24. Proskocil BJ, Sekhon HS, Jia Y, Savchenko V, Blakely RD, Lindstrom J, et al. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinology 2004; 145: 2498-2506.
25. Español AJ, de la Torre E, Fiszman GL, Sales ME. Role of non-neuronal cholinergic system in breast cancer progression. Life Sci 2007; 80: 2281-2285.
26. Rimmaudo LE, de la Torre E, Sacerdote de Lustig E, Sales ME. Muscarinic receptors are involved in LMM3 tumor cells proliferation and angiogenesis. Biochem Biophys Res Commun 2005; 334: 1359-1364.
27. Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, et al. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 2008; 7: 1789-1796.
28. Pei Z, Lin D, Song X, Li H, Yao H. TLR4 signaling promotes the expression of VEGF and TGFbeta1 in human prostate epithelial PC3 cells induced by lipopolysaccharide. Cell Immunol 2008; 254: 20-27.
29. Suriyo T, Thiantanawat A, Chaiyaroj SC, Parkpian P, Satayavivad J. Involvement of the lymphocytic muscarinic acetylcholine receptor in methylmercury-induced c-Fos expression and apoptosis in human leukemic T cells. J Toxicol Environ Health A 2008; 71: 1109-1123.
30. Qiu YH, Peng YP, Jiang JL, Wang JJ. Effect of acetylcholine on in vitro IL-2 production and NK cell cytotoxicity of rats. Lymphology 2004; 37: 31-38.
31. Qiu YH, Peng YP, Jiang JL, Wang JJ. Effect of acetylcholine on in vitro IL-2 production and NK cell cytotoxicity of rats. Lymphology 2004; 37: 31-38.
32. Fujii T, Takada-Takatori Y, Kawashima K. Basic and clinical aspects of non-neuronal acetylcholine: Expression of an independent, non-neuronal cholinergic system in lymphocytes and its clinical significance in immunotherapy. J Pharmacol Sci 2008; 106: 186-192.